Clinical Trial Results:
Open-label, phase II, ramdomised, pilot study to evaluate the safety and efficacy of combination therapy with cetuximab and FOLFOX4 or FOLFOX4 alone in patients with EGFR-pos. colorectal cancer and initially non-resectable
Estudio piloto fase II abierto y aleatorizado para evaluar la eficacia y seguridad de la combinación de cetuximab con folfox4 y folfox4 solo en pacientes con cáncer colorrectal que exprese EGFR y metástasis hepáticas exclusivas no resecables de entrada.
Summary
|
|
EudraCT number |
2004-001700-12 |
Trial protocol |
ES |
Global completion date |
27 Sep 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Apr 2019
|
First version publication date |
24 Apr 2019
|
Other versions |
|
Summary report(s) |
TTD0402_Synopsis_Final |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.